FDA

Covid boosters targeting omicron are coming. Here’s what you need to know about them.Covid boosters targeting omicron are coming. Here’s what you need to know about them.

As early as this weekend, people in the U.S. may be able to walk into their local pharmacy and get a reformulated covid-19 booster, the first update to the shots since the pandemic started.

Jonathan Lambert, Public Health Reporter

September 2, 2022

The FDA’s big plan to expand its monkeypox vaccine supply — up to fivefoldThe FDA’s big plan to expand its monkeypox vaccine supply — up to fivefold

Injecting a smaller amount of vaccine into the skin could stretch existing supply, but there’s not much data to go on.

Jonathan Lambert, Public Health Reporter

August 9, 2022

The world had a head start with monkeypox vaccines. It has largely squandered it.The world had a head start with monkeypox vaccines. It has largely squandered it.

The U.S. has struggled to get monkeypox vaccine to those who need it, and Africa has no access to the shots.

Jonathan Lambert, Public Health Reporter

August 4, 2022

An FDA official bolting to Big Tobacco shines a light on the agency’s revolving-door problemAn FDA official bolting to Big Tobacco shines a light on the agency’s revolving-door problem

LinkedIn profile data suggests that at least 2,700 ex-FDA employees now work for the pharmaceutical industry. Another 1,100 current FDA employees have moved the other way, from industry to the agency.

Dan Vergano, Science Reporter

August 3, 2022

The tricky scientific question underlying FDA’s crackdown on Juul and vapingThe tricky scientific question underlying FDA’s crackdown on Juul and vaping

The Food and Drug Administration’s decision last week to ban Juul’s vaping products illustrates how much of a conundrum electronic cigarettes pose to regulators.

Jonathan Lambert, Public Health Reporter

June 30, 2022